-- 獨立研究機構CFRA向提供了以下研究報告。 CFRA分析師總結如下:TWLO公佈2026年第一季銷售額為14.1億美元(年增20%),遠超市場預期(13.4億美元)。有機成長率從上一季的12%加速至16%,也高於先前約10.5%的預期。非GAAP每股收益為1.50美元(年成長32%),顯著高於市場預期(1.27美元)。營業利益率為19.8%(年成長160個基點),高於TWLO先前18.3%的預期中位數,反映出公司持續的效率提升,與前期表現類似,這也是我們看好該公司業績的關鍵因素。 GAAP營業利益率從第四季的4%提升至8%,主要得益於SBC業務佔營收的比例從第四季的11%降至10%。該公司預計第二季銷售額將達到14.25億美元(年增16%,高於市場預期2.5%),並將全年有機成長預期從約8.5%上調至約10%。隨著人工智慧產品獲得市場認可,我們認為公司仍有成長空間。受非有機銷售成長的推動,DBNER(數據淨增率)從上一季的109%飆升至114%。新增4.3萬個活躍客戶帳戶,使活躍客戶總數達到約45萬,顯示公司客戶獲取勢頭強勁,我們預計這一趨勢將持續下去。
Related Articles
Shanghai International Airport's Q1 Profit Rises 11%
Shanghai International Airport's (SHA:600009) net profit attributable to shareholders in the first quarter rose 11% to 577.8 million yuan from the year-ago attributable profit of almost 519.0 million yuan, according to a Shanghai bourse filing on Thursday.Earnings per share climbed 10% year on year to 0.23 yuan from 0.21 yuan.Operating revenue inched 0.8% higher to 3.20 billion yuan from 3.17 billion yuan in the preceding year.
Shanghai International Airport's 2025 Profit Rises 10%, Revenue Climbs 8%
Shanghai International Airport's (SHA:600009) net profit attributable to shareholders in 2025 rose 9.5% to 2.12 billion yuan from 1.93 billion yuan a year earlier, according to a Shanghai bourse filing on Thursday.Earnings per share climbed 9% year on year to 0.85 yuan from 0.78 yuan.Operating revenue gained 7.9% to 13.35 billion yuan from 12.37 billion yuan in the previous year.
ResMed CFO to Retire
ResMed (ASX:RMD) said that Chief Financial Officer Brett Sandercock plans to retire, effective May 4, according to a Friday statement by the company.Aaron Bloomer will succeed Sandercock, who will remain an adviser to the chief executive through 2027, the company said.Bloomer was CFO of Exact Sciences, which was recently acquired by New York Stock Exchange-listed Abbott.